69 Best Drug Delivery Startups to Watch in 2025

The Definitive Seedtable Ranking of Drug Delivery Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 179 start-ups with an aggregate funding of $3.5b. The average funding per company in this subset is $51.0m.

Last update to the database: Feb 18, 2025. See changelog.

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up
Neos Therapeutics logo

Neos Therapeutics

Neos Therapeutics is a pharmaceutical company developing ADHD medications founded in 2008.

1

Funding Rounds

$24.1m

Money raised

ViaCyte logo

ViaCyte

ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.

16

Funding Rounds

$328.8m

Money raised

Eligo Bioscience logo

Eligo Bioscience

Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.

9

Funding Rounds

$82.6m

Money raised

Ligandal logo

Ligandal

Nanomedicine company developing vaccines and therapies with cell-specific targeting.

6

Funding Rounds

$4.6m

Money raised

Prokarium logo

Prokarium

Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.

6

Funding Rounds

$86.6m

Money raised

Evox Therapeutics logo

Evox Therapeutics

An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.

3

Funding Rounds

$143.4m

Money raised

Oisin Biotechnologies logo

Oisin Biotechnologies

Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.

4

Funding Rounds

$7.1m

Money raised

CeQur logo

CeQur

CeQur is a wearable mealtime insulin device maker founded in 2008 by Joël Besse.

2

Funding Rounds

$56.6m

Money raised

Juventus Therapeutics logo

Juventus Therapeutics

Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.

4

Funding Rounds

$46.7m

Money raised

CHAIN Biotechnology logo

CHAIN Biotechnology

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

2

Funding Rounds

$645.0k

Money raised

TFF Pharmaceuticals logo

TFF Pharmaceuticals

TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.

2

Funding Rounds

$22.2m

Money raised

Encellin logo

Encellin

Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.

1

Funding Rounds

$5.9m

Money raised

Tempo Therapeutics logo

Tempo Therapeutics

Tempo Therapeutics is an interventional biomaterials for regenerative medicine company founded by Westbrook Weaver.

1

Funding Rounds

$3.9m

Money raised

Xycrobe Therapeutics logo

Xycrobe Therapeutics

Xycrobe Therapeutics is a biotechnology company developing microbiome-Based, biotherapeutic delivery systems.

1

Funding Rounds

$400.0k

Money raised

Anjarium Biosciences logo

Anjarium Biosciences

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

3

Funding Rounds

$121.0m

Money raised

Kernal Biologics logo

Kernal Biologics

Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.

3

Funding Rounds

$50.6m

Money raised

Ablitech, Inc. logo

Ablitech, Inc.

A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.

1

Funding Rounds

$2.0m

Money raised

Cerebral Therapeutics logo

Cerebral Therapeutics

A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.

5

Funding Rounds

$93.6m

Money raised

Aryx Therapeutics logo

Aryx Therapeutics

A pharmaceutical company developing oral therapies for chronic diseases.

1

Funding Rounds

$21.6m

Money raised

Diadem Biotherapeutics logo

Diadem Biotherapeutics

Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease

1

Funding Rounds

CellCentric logo

CellCentric

CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.

13

Funding Rounds

$123.5m

Money raised

Diabeloop logo

Diabeloop

Diabeloop is a Grenoble-based company founded in 2015.

3

Funding Rounds

$191.8m

Money raised

Vaxxas logo

Vaxxas

Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.

1

Funding Rounds

$22.8m

Money raised

Orexo logo

Orexo

Orexo is a pharmaceutical company developing and commercializing drugs founded in 1995 by Anders Pettersson, Christer Nyström and Thomas Lundqvist.

2

Funding Rounds

$72.9m

Money raised

Entos Pharmaceuticals Inc. logo

Entos Pharmaceuticals Inc.

Entos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.

1

Funding Rounds

Pulmocide logo

Pulmocide

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

3

Funding Rounds

$152.8m

Money raised

PepVax logo

PepVax

PepVax Inc. is a Washington DC-based biotechnology company.

2

Funding Rounds

$8.5m

Money raised

GenEdit logo

GenEdit

GenEdit develops technology for gene editing.

3

Funding Rounds

$34.5m

Money raised

Carmine Therapeutics logo

Carmine Therapeutics

Carmine Therapeutics is a Cambridge, Massachusetts-based company developing novel types of gene therapies utilizing extracellular vesicles produced in laboratory.

1

Funding Rounds

$3.4m

Money raised

RepliCel Life Sciences logo

RepliCel Life Sciences

RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy.

1

Funding Rounds

$594.1k

Money raised

PDX Pharmaceuticals, Inc. logo

PDX Pharmaceuticals, Inc.

PDX Pharmaceuticals, Inc. is a company in the pharmaceuticals industry founded by Wassana Yantasee in 2010.

2

Funding Rounds

$5.6m

Money raised

Bionaut Labs logo

Bionaut Labs

Bionaut Labs develops precision medicine treatments for CNS disorders.

2

Funding Rounds

$20.0m

Money raised

Bigfoot Biomedical logo

Bigfoot Biomedical

Bigfoot Biomedical is an insulin delivery pump founded in 2014.

4

Funding Rounds

$194.9m

Money raised

Corium International logo

Corium International

Corium International is a transdermal Generics, Consumer Products founded in 1999.

1

Funding Rounds

$40.0m

Money raised

leon-nanodrugs GmbH logo

leon-nanodrugs GmbH

leon-nanodrugs is a Bayern, Germany-based company that specializes in researching and developing nanotechnology-based drugs.

2

Funding Rounds

$22.3m

Money raised

Sixfold Bioscience logo

Sixfold Bioscience

Sixfold Bioscience is a biotechnology firm focused on advancing RNA therapies founded in 2017 by Anna Perdrix Rosell, Zuzanna Brzosko and George Foot.

1

Funding Rounds

$10.0m

Money raised

Collegium Pharmaceutical logo

Collegium Pharmaceutical

Collegium Pharmaceutical is a company developing products for pain management founded in 2002.

1

Funding Rounds

$22.5m

Money raised

AmacaThera logo

AmacaThera

AmacaThera is a hydrogel-based drug delivery founded in 2016 by Molly Shoichet.

3

Funding Rounds

$16.4m

Money raised

Pantec Biosolutions AG logo

Pantec Biosolutions AG

Pantec Biosolutions AG develops drug delivery solutions for a variety of medical applications.

1

Funding Rounds

$6.9m

Money raised

SiSaf logo

SiSaf

SiSaf is the first company to create a Bio-Courier platform technology.

4

Funding Rounds

NanoMedical Systems logo

NanoMedical Systems

NanoMedical Systems is a personalized Molecular Drug-delivery System Implant founded in 2007 by Mauro Ferrari, David D. Saathoff and Randy Goodall.

5

Funding Rounds

$12.2m

Money raised

Xilis logo

Xilis

Micro-organosphere technologies to guide precision therapy for cancer patients

3

Funding Rounds

$92.0m

Money raised

Gilero logo

Gilero

Gilero is a Morrisville, North Carolina-based company offering device design, development, and contract manufacturing services in the medical and pharmaceutical industries.

1

Funding Rounds

$11.5m

Money raised

Sensulin logo

Sensulin

Sensulin is an insulin manufacturing company founded by Ananth Annapragada, Mike Moradi, Chris Rhodes and Dan Bradbury.

2

Funding Rounds

$330.0k

Money raised

Lyndra Therapeutics (company) logo

Lyndra Therapeutics (company)

Lyndra Therapeutics is a drug Delivery founded in 2015.

3

Funding Rounds

$143.0m

Money raised

Vesigen Therapeutics logo

Vesigen Therapeutics

Vesigen Therapeutics is a company in Cambridge, Massachusetts.

1

Funding Rounds

$2.9m

Money raised

VALANX Biotech logo

VALANX Biotech

VALANX Biotech is a company enabling antibody drug conjugates

1

Funding Rounds

$2.4m

Money raised

Ceptur Therapeutics logo

Ceptur Therapeutics

Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases

2

Funding Rounds

$150.0m

Money raised

Pharmaco-Kinesis Corporation logo

Pharmaco-Kinesis Corporation

Pharmaco-Kinesis Corporation is a high-end medical device technology company.

2

Funding Rounds

$17.2m

Money raised

Pharnext logo

Pharnext

Pharnext is a very well advanced clinical-stage biopharmaceutical company

3

Funding Rounds

$19.9m

Money raised

Flexion Therapeutics logo

Flexion Therapeutics

Flexion Therapeutics is an american biotechnology company founded in 2007.

2

Funding Rounds

$53.0m

Money raised

Aprecia Pharmaceuticals logo

Aprecia Pharmaceuticals

A company developing precision drug delivery systems and products

2

Funding Rounds

$30.1m

Money raised

Periphagen Inc logo

Periphagen Inc

Periphagen is a biopharmaceutical company founded in 2012 by Darren Wolfe

2

Funding Rounds

$22.5m

Money raised

PEP-Therapy logo

PEP-Therapy

Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.

1

Funding Rounds

$3.1m

Money raised

Ablative Solutions logo

Ablative Solutions

A medical device company developing surgical renal denervation for the treatment of hypertension

3

Funding Rounds

$159.3m

Money raised

Orna Therapeutics logo

Orna Therapeutics

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics.

2

Funding Rounds

$321.0m

Money raised

InCarda Therapeutics logo

InCarda Therapeutics

InCarda Therapeutics is a company developing therapies for cardiovascular diseases founded in 2009 by Carlos A. Schuler.

2

Funding Rounds

$72.1m

Money raised

Cello Therapeutics, Inc. logo

Cello Therapeutics, Inc.

Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment.

1

Funding Rounds

$1.6m

Money raised

QurCan Therapeutics Inc. logo

QurCan Therapeutics Inc.

Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.

1

Funding Rounds

$3.0m

Money raised

CF PharmTech logo

CF PharmTech

CF PharmTech is a specialty Respiratory Pharmaceuticals founded in 2007.

1

Funding Rounds

$65.0m

Money raised

3Bar Biologics logo

3Bar Biologics

3Bar Biologics is a microbe delivery and manufacturing company that partners with microbe discovery and commercialization companies.

2

Funding Rounds

$3.0m

Money raised

BioLight Life Sciences Ltd. logo

BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd. is devoted to the development of products and diagnostic solutions for ophthalmic conditions.

2

Funding Rounds

$10.2m

Money raised

Microdermics logo

Microdermics

Microdermics is a skincare company founded in 2014 by Grant Campany, Boris Stoeber, Sahan Ranamukhaarachchi and Iman Mansoor.

2

Funding Rounds

$1.5m

Money raised

EnClear Therapies logo

EnClear Therapies

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

3

Funding Rounds

$12.0m

Money raised

410 Medical Inc logo

410 Medical Inc

410 Medical Inc is an emergency Infusion Device founded in 2013.

7

Funding Rounds

$27.6m

Money raised

Ring Therapeutics logo

Ring Therapeutics

Ring Therapeutics is a multi-product platform company.

2

Funding Rounds

$167.0m

Money raised

2C Tech Corporation, Inc. logo

2C Tech Corporation, Inc.

2C Tech Corporation, Inc. is a nanoparticles for Ophthalmology founded by Naresh Mandava.

3

Funding Rounds

$5.5m

Money raised

Adocia logo

Adocia

Adocia is a molecular Delivery System for Therapeutic Proteins founded in 2005.

4

Funding Rounds

$57.1m

Money raised

Chameleon Biosciences Inc. logo

Chameleon Biosciences Inc.

Chameleon Biosciences Inc. is a gene therapy company.

2

Funding Rounds

$3.1m

Money raised